USRE31588EExpiredUtility

Imidazolylmethylthioethyl alkynyl guanidines

Priority: Jun 3, 1977Filed: Jun 16, 1981Granted: May 22, 1984
Est. expiryJun 3, 1997(expired)· nominal 20-yr term from priority
C07C 323/44C07D 277/64C07D 233/64
11
PatentIndex Score
1
Cited by
46
References
10
Claims

Abstract

Compounds of the formula ##STR1## wherein R 1 is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms, inclusive, and nontoxic pharmaceutically acceptable acid addition salts thereof, are potent anti-ulcer agents.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A compound of the formula ##STR24## wherein R 1  is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms, inclusive, or a nontoxic pharmaceutically acceptable acid addition salt thereof. 
     
     
       2. A compound of the formula ##STR25## wherein R 4  is hydrogen or methyl, or a nontoxic pharmaceutically acceptable acid addition salt thereof. 
     
     
       3. A compound of the formula ##STR26## wherein R 4  is hydrogen or methyl and n is an integer of from 1 to 6, inclusive, or a noxtoxic pharmaceutically acceptable acid addition salt thereof. .[. 
     
     
       4.  A compound of the formula ##STR27## wherein R 4  is hydrogen or methyl, or a nontoxic pharmaceutically acceptable acid addition salt thereof..]. 
     
     
       5. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-propargylguanidine or a nontoxic pharmaceutically acceptable acid addition salt thereof. 
     
     
       6. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-propargylguanidine. 
     
     
       7. A nontoxic pharmaceutically acceptable salt of N-cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-propargylguanidine. 
     
     
       8. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(2-butyn-1-yl)guanidine or a nontoxic pharmaceutically acceptable acid addition salt thereof. 
     
     
       9. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(3-butyn-1-yl)guanidine or a nontoxic pharmaceutically acceptable salt thereof. 
     
     
       10. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(4-pentyn-1-yl)guanidine or a nontoxic pharmaceutically acceptable acid addition salt thereof. .[.11. N-Cyano-N-'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(2-methyl-3-butyn-2-yl)guanidine or a nontoxic pharmaceutically acceptable acid addition 
     
     
        salt thereof..]. 12. N-Cyano-N'-{2-[(4-methyl-5-imidazolyl)methylthio]ethyl}-N"-(3-butyn-2-yl)guanidine or a nontoxic pharmaceutically acceptable acid addition salt thereof.

Join the waitlist — get patent alerts

Track USRE31588E — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.